Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02598778 · ClinicalTrials.gov registry record · Phase 2
Comparing Mouth Rinses (and Chewing Gum) in Regard to Streptococcus Mutans Reduction
A Phase 2 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT02598778 is a Phase 2 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 12 participants.
The verdict
NCT02598778, a Phase 2 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study compared four mouth rinses/chews for their ability to reduce Streptococcus Mutans after usage. The four that were compared were chlorhexidine gluconate (0.12%), sodium fluoride (0.05%), paraffin wax chewing gum (sugar free), and deionized water. The paraffin wax chewing gum replaced the originally planned coconut oil and served as a placebo comparator.
Interventions
- DRUG Chlorhexidine gluconate (0.12%)
- DRUG Sodium Fluoride (0.05%)
- OTHER Paraffin wax chewing gum (sugar-free)
- OTHER Deionized water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-11-01 |
| Est. Completion | 2016-04-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02598778
The ClinicalTrials.gov registry entry for NCT02598778 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Chlorhexidine gluconate (0.12%) is the first listed.
NCT02598778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02598778 about?
NCT02598778 is a clinical study titled "Comparing Mouth Rinses (and Chewing Gum) in Regard to Streptococcus Mutans Reduction". This study compared four mouth rinses/chews for their ability to reduce Streptococcus Mutans after usage. The four that were compared were chlorhexidine gluconate (0.12%), sodium fluoride (0.05%), paraffin wax chewing gum (sugar free), and deionized water. The paraffin wax chewing gum replaced the o...
What is the current status of trial NCT02598778?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2015-11-01. Estimated completion is 2016-04-01.
What interventions are being tested in trial NCT02598778?
The interventions under investigation include: Chlorhexidine gluconate (0.12%) (DRUG), Sodium Fluoride (0.05%) (DRUG), Paraffin wax chewing gum (sugar-free) (OTHER), Deionized water (OTHER).
Who is sponsoring clinical trial NCT02598778?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.